Purified Vero Rabies Vaccine (VRVg) + Imovax® Rabies: inactivated rabies vaccine
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedAbout Purified Vero Rabies Vaccine (VRVg) + Imovax® Rabies: inactivated rabies vaccine
Purified Vero Rabies Vaccine (VRVg) + Imovax® Rabies: inactivated rabies vaccine is a phase 2 stage product being developed by Sanofi for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT01877395. Target conditions include Rabies.
What happened to similar drugs?
2 of 15 similar drugs in Rabies were approved
Approved (2) Terminated (0) Active (13)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01877395 | Phase 2 | Completed |
Competing Products
20 competing products in Rabies